BIOWA INC. - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/86616.xml BIOWA INC. - Press Releases en xml@emediawire.com xml@emediawire.com 30 BioWa Appoints Spitalny Vice President, Research & Development http://www.prweb.com/releases/2005/04/prweb234642.htm BioWa, Inc. has announced the appointment of George Spitalny, PhD, to Vice President, Research and Development. Dr. Spitalny will be responsible for further development of the company’s product pipeline, in particular the anti-IL-5 receptor monoclonal antibody (Mab) being developed for the treatment of non-allergic asthma recently licensed from Kyowa Hakko Kogyo Co., Ltd., Japan. (PRWeb Apr 30, 2005)

Read the full story at http://www.prweb.com/releases/2005/04/prweb234642.htm

]]> http://www.prweb.com/releases/2005/04/prweb234642.htm BioWa, Inc., Licenses Anti IL-5 Receptor Antibody from Kyowa Hakko Kogyo Co, Ltd. http://www.prweb.com/releases/2005/03/prweb220570.htm BioWa has successfully licensed from Kyowa Hakko Kogyo Co, Ltd, the exclusive worldwide rights except Asia to develop and commercialize anti IL-5 receptor antibody, a potential new asthma treatment. (PRWeb Mar 23, 2005)

Read the full story at http://www.prweb.com/releases/2005/03/prweb220570.htm

]]> http://www.prweb.com/releases/2005/03/prweb220570.htm BioWa Announces New Generation of Technology: Potelligent™ RNAi http://www.prweb.com/releases/2005/02/prweb205331.htm BioWa is proud to introduce a new version of this revolutionary technology: Potelligent™ RNAi. (PRWeb Feb 5, 2005)

Read the full story at http://www.prweb.com/releases/2005/02/prweb205331.htm

]]> http://www.prweb.com/releases/2005/02/prweb205331.htm BioWa Receives Milestone Payment from Medarex http://www.prweb.com/releases/2005/01/prweb199547.htm BioWa, Inc. today announced that it has received an undisclosed milestone payment from its partner, Medarex, Inc. (PRWeb Jan 21, 2005)

Read the full story at http://www.prweb.com/releases/2005/01/prweb199547.htm

]]> http://www.prweb.com/releases/2005/01/prweb199547.htm BioWa Announces the Licensing of its Potelligent Technology to Biogen Idec http://www.prweb.com/releases/2004/06/prweb136004.htm BioWa, Inc. announced that the company has granted a commercial license to Biogen Idec Inc. to use BioWa's Potelligent Technology for the enhancement of ADCC. (PRWeb Jun 29, 2004)

Read the full story at http://www.prweb.com/releases/2004/06/prweb136004.htm

]]> http://www.prweb.com/releases/2004/06/prweb136004.htm